Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06868368 · ClinicalTrials.gov registry record · NA

Perceptions of Vaping Products

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT06868368 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 53 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06868368, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

This clinical trial studies the effects, appeal, and abuse liability of 6-methyl nicotine (metatine) electronic cigarettes among young adults.

Interventions

  • OTHER Survey Administration
  • OTHER Biospecimen Collection
  • BEHAVIORAL Vaping Topography
  • OTHER Participant's Own Preferred E-cigarette
  • OTHER Nicotine E-cigarette

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2025-03-03
Est. Completion 2025-11-04
Phase NA

What the Registry Record Tells You About NCT06868368

The ClinicalTrials.gov registry entry for NCT06868368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.

NCT06868368 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06868368 about?

NCT06868368 is a clinical study titled "Perceptions of Vaping Products". This clinical trial studies the effects, appeal, and abuse liability of 6-methyl nicotine (metatine) electronic cigarettes among young adults.

What is the current status of trial NCT06868368?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2025-03-03. Estimated completion is 2025-11-04.

What interventions are being tested in trial NCT06868368?

The interventions under investigation include: Survey Administration (OTHER), Biospecimen Collection (OTHER), Vaping Topography (BEHAVIORAL), Participant's Own Preferred E-cigarette (OTHER), Nicotine E-cigarette (OTHER).

Who is sponsoring clinical trial NCT06868368?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.